The kit is intended for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus.
The kit is designed for detection of DNA of 5 pathogens of urogenital infections.
The reagent kit is intended for early non-invasive diagnosis of prostate cancer by detecting the chimeric TMPRSS2-ERG gene and determining the expression level of the PCA3 gene, specific for prostate cancer, in relation to the level of the KLK3 gene, characteristic only for prostate tissue.
The kits can't be used for diagnostics of any pathology and are designed only for qualitative determination of the status of mutations to determine indications for targeted therapy.
Reagent kits cannot be used to diagnose any pathology and are intended only for qualitative determination of the NRAS gene mutation status to determine indications for targeted therapy.